(Natural News)—The American Heart Association (AHA) has announced a sweeping redefinition of cardiovascular disease (CVD), coining a new term: cardiovascular-kidney-metabolic (CKM) syndrome. This revelation, published in the journal Circulation, suggests that an astonishing 90 percent of U.S. adults may now be affected by this newly identified syndrome, which encompasses cardiovascular disease, kidney issues and metabolic disorders. According to the AHA, most of the population now exhibit symptoms of this new disease, and should be screened regularly to prevent early heart attacks and strokes.
This new syndrome comes on the heels of a global mRNA vaccine experiment that destroyed human blood composition and quality and exacerbated inflammation throughout the body. This experiment infiltrated the human race with foreign spike proteins that caused widespread blood clotting disorders, myocarditis and pericarditis, while interfering with normal, healthy protein and hormone production of the cell. One study found an increased risk of epilepsy, severe allergic shock, myocarditis and appendicitis in children injected with COVID-19 vaccines, indicating systemic blood and immunological damage.
AHA won’t address the causes of this new disease
The AHA’s announcement raises significant questions about the causes behind such a widespread health crisis. According to the AHA’s recent statistical update, nearly one-third of American adults are believed to have multiple risk factors contributing to CKM syndrome, including obesity, Type 2 diabetes and kidney disease. The Journal of the American Medical Association (JAMA) corroborates these findings, noting that 90 percent of U.S. adults meet the criteria for CKM syndrome at stage 1 or higher. The lack of historical data — CKM syndrome was only introduced last fall — adds a layer of complexity to understanding the implications of this diagnosis.
The study highlights significant demographic disparities, with older adults, men and black individuals facing the greatest risk. However, the study does not address any environmental causes for this condition. The elephant in the room is the mRNA vaccine experiment, which harms all of these physiological processes mentioned in the new diagnostic guidelines. For instance, an Oxford study revealed that COVID-19 mRNA vaccines are the sole cause of heart inflammation and heart failure in children.
New disease label mirrors the damage done by global mRNA vaccine experiment
The invention of this new disease label demands an urgent and thorough investigation into potential root causes, particularly with the mRNA vaccines, which damage all these organ and endocrine systems of the body. Instead of addressing these critical inquiries, however, mainstream medical discourse appears to be pivoting toward the development of new treatments, positioning pharmaceutical giants like Pfizer and Merck to benefit significantly from this shift. In fact, Pfizer has already begun acquiring drug companies to profit from chronic diseases caused by their own COVID-19 “vaccines.”
While the AHA’s new classification of CKM syndrome could lead to advancements in treatment, there is a conspicuous lack of emphasis on prevention or root cause analysis. Instead, the focus is on managing symptoms and prescribing patented medications — a stark contrast to the traditional adage, “an ounce of prevention is worth a pound of cure.”
Shouldn’t medical authorities be asking basic questions about the sudden emergence of a new medical condition that impacts nearly an entire population? Slapping a new label on most Americans doesn’t fix the problem, but it does set individuals up to be patients for life, while covering up the root causes.
The disconnection between diagnosis and proactive healthcare solutions raises critical ethical concerns. As the medical community gears up for potential profit-driven initiatives surrounding CKM syndrome, the question looms: Is genuine healthcare the priority, or merely the expansion of a corporate healthcare model that prioritizes the lifelong drugging of patients over prevention and addressing root causes?
Sources include:
- Armageddonepose.substack.com
- NaturalNews.com
- NaturalNews.com
- NaturalNews.com
- NaturalNews.com
- NaturalNews.com
Bypass Big Tech Censors
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.
